. Effectiveness of inhibited nitric oxide combined with oral sildenafil for the treatment of serious congenital diaphragmatic hernia[J]. CJCP, 2014, 16(9): 944-946.
Reiss I, Schaible T, van den Hout L, et al.Standardized postnatal management of infants with congenital diaphragmatic hernia in Europe: the CDH EURO Consortium consensus[J].Neonatology, 2010, 98(4): 354-364.
[2]
Tracy ET, Mears SE, Smith PB, et al.Protocolized approach to the management of congenital diaphragmatic hernia: benefits of reducing variability in care[J].J Pediatr Surg, 2010, 45(6):1343-1348.
Logan JW, Rice HE, Goldberg RN, et al.Congenital diaphragmatic hernia: a systematic review and summary of best-evidence practice strategies[J].J Perinatol, 2007, 27(9): 535-549.
[6]
Muraca MC, Negro S, Sun B, et al.Nitric oxide in neonatal hypoxemic respiratory failure[J].J Matern Fetal Nionatal Med,2012(Suppl): 47050.
[7]
Noori S, Friedlich P, Wong P, et al.Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension[J].Neonatology, 2007,91(2): 92-100.
[8]
Luong C, Rey-Perra J, Vadivel A, et al.Antenatal sildenafil treatment attenuates pulmonary hypertension in experimental congenital diaphragmatic hernia[J].Circulation, 2011, 123(19):2120-2131.
